Company intelligence / Profile preview

Bio-Star

Xianyang, Shaanxi, China

Ownership: Private
Development stage: Other

Overview

Biostar Pharmaceuticals is a China-based pharmaceutical company that specializes in the development, manufacture, and marketing of pharmaceutical products and health supplements. The company's portfolio includes both conventional chemical drugs and Traditional Chinese Medicine (TCM), with a primary focus on liver diseases and inflammatory conditions. Its lead products have historically included XinAoxin for Hepatitis B and Aoxing Oleanolic Acid capsules for chronic hepatitis. While the company was previously listed on the NASDAQ, it has faced significant regulatory and financial challenges, leading to its delisting and a transition to inactive status in major international markets.

Therapeutic areas: OncologyRheumatologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Bio-Star.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Star.

Explore the full profile